PRNewsWire
19 Jun 2026, 21:50 UTC · 1h ago
Zoetis Inc. (ZTS) Class Action Lawsuit: Investors July 27 2026, Deadline - Contact KTMC
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
PRNewsWire
19 Jun 2026, 21:50 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Zoetis reported a significant decline across its Companion Animal business in Q1 2026, resulting in a 21.5% stock price drop on May 7, 2026. — A sudden, double-digit percentage drop driven by core business deterioration is a strong signal of weakened fundamental value.
-0.80A securities fraud class action lawsuit has been filed alleging Zoetis misrepresented the growth of Librela following FDA safety warnings regarding neurological complications. — Regulatory safety warnings and subsequent litigation regarding a key product suggest potential long-term revenue loss and legal liabilities.
-0.60The company is allegedly losing significant market share in its Simparica Trio, Apoquel, and Cytopoint product lines to lower-priced competitors. — Loss of market share to cheaper alternatives indicates pricing pressure and a decline in the company's competitive moat.
-0.50Continue reading
6 related stories
Top 2 movers · tap to explore
Investors have until July 27, 2026, to file for lead plaintiff status in the class action lawsuit filed in the Southern District of New York. — While a procedural step, the formalization of a class action adds a layer of ongoing legal risk and potential settlement costs.
-0.20Which stocks this story touches
The company is facing a securities fraud class action lawsuit and experienced a 21.5% stock price drop following reports of declining business performance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
3h ago
